Greater uptake, an alternative reimbursement methodology needed to realize cost-saving potential of oncology biosimilars in the United States
提高接受度，需要一种替代性的报销方法，才能在美国充分发挥肿瘤生物类似药的成本节约潜力。
期刊:
影响因子:
doi:10.18553/jmcp.2021.21202
Yang, Jingyan; Carioto, Jennifer; Pyenson, Bruce; Smith, Rebecca; Jacobson, Nathaniel; Pittinger, Sean; Shelbaya, Ahmed
